Tuesday, May 05, 2020 1:00:34 PM
In 2017 OWCP stated that they were applying with the FDA for Multiple Myeloma Orphan Drug Status - of course that still hasn't happened.
OWCP hasn't applied for FDA approved clinical trials for the multiple myeloma drug.
If these patents were so valuable why did Bignitz and Hirsch walk away?
The much pumped psoriasis cream patent caused a small blip in the price - but it quickly lost those gains.
OWCP have been talking about the "patents" for years - since the OWCP/Friedland pump the price is down 99%.
IG
"And the CEO looked, and behold a pale horse: and his name that sat on him was Death to Scams, and Hell followed with him."
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM